Clinical trial Recruiting at 3 sites Interventional

Comparing treatments for acute atrial fibrillation and flutter

Official title: Acute Atrial Fibrillation and Flutter Treated Electively - A Randomized Controlled Clinical Trial on the Safety of Elective Management of Acute Atrial Fibrillation and Flutter

Run by Tampere University · NCT04267159 · Data updated 2026-11-12

This study is testing two different ways to treat people with sudden atrial fibrillation or flutter in the emergency room to see if a less immediate approach can be done safely.

Quick facts

Study typeInterventional
SexAll
Enrollment500 (estimated)
SponsorTampere University
Academic / other
Locations4 sites (Jyväskylä, Central Finland and 3 other locations)
StatusRecruiting
StartedFebruary 10, 2020
Main results expectedJune 2027
Study endsJune 2029
Registry record updatedMay 22, 2026
Trial IDNCT04267159 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include patients presenting with acute atrial fibrillation or flutter within 48 hours who are in good clinical condition.

Probably not a fit

Patients with hemodynamic instability or other major acute illnesses may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The AFFELECT study evaluates two treatment approaches for patients with acute atrial fibrillation or flutter who require rhythm control. Patients presenting to the emergency department will be randomly assigned to either conventional care, which involves immediate cardioversion, or elective care, where they are discharged after temporary rhythm control is achieved. Follow-up visits with a cardiologist will occur approximately one week after the emergency room visit to assess the effectiveness of the treatment. The goal is to determine if elective treatment can be safely implemented within a short timeframe.

Why it matters

Potential benefit: If successful, this study could provide a safer and more efficient treatment option for patients with acute atrial fibrillation and flutter.

How similar studies have gone: While there have been studies on rhythm control in atrial fibrillation, this specific approach of elective treatment within a short timeframe is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients presenting with acute (\<48hours) atrial fibrillation or atrial flutter to ER
* Planned acute rhythm control for the arrhythmia by the attending physician in ER
* Good perceived health as assessed by attending physician in ER
* Resting heart rate 110bpm or lower before or after adequate rate control therapy

Exclusion Criteria:

* Haemodynamically stable (mean arterial pressure above 60mmHg)
* Need for acute restoration of sinus rhythm due to some other somatic cause
* No other major complicating acute illness (e.g. decompensated HF or acute MI)
* Anticoagulation not safe
* Mechanical heart valve or mitral stenosis
* The need for prolonged (\>24h) hospitalization due to any cause
* Exceptionally high risk for thromboembolic events (e.g. history of thromboembolic stroke regardless of adequate anticoagulation)
* Transesophageal echocardiography contraindicated

Where it's running

  • Central Finland Central Hospital
    Jyväskylä, Central Finland, Finland
    Recruiting
  • Kanta-Häme Central Hospital
    Hämeenlinna, Kanta-Häme, Finland
    Recruiting
  • Tampere University Hospital
    Tampere, Pirkanmaa, Finland
    Recruiting
  • Päijät-Häme Central Hospital
    Lahti, Paijat-Hame Region, Finland
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.